Alteration in P-glycoprotein at the blood-brain barrier in the early period of MCAO in rats

Journal of Pharmacy and Pharmacology

Volumn 65, Issue 5, 2013, Pages 665-672

  Cen, Juan ^a   Liu, Lu ^a   Li, Ming Shan ^a   He, Ling ^b   Wang, Li Juan ^a   Liu, Yan Qing ^a   Liu, Meng ^a   Ji, Bian Sheng ^a  

^a HENAN UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

blood brain barrier; middle cerebral artery occlusion; P glycoprotein

Indexed keywords

CLAUDIN 5; FLUORESCEIN SODIUM; GELATINASE A; GELATINASE B; MULTIDRUG RESISTANCE PROTEIN; NIMODIPINE; NITRIC OXIDE SYNTHASE; RHODAMINE 123; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN TISSUE; CONTROLLED STUDY; HEMISPHERE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN ISCHEMIA; CLAUDIN-5; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NITRIC OXIDE SYNTHASE; P-GLYCOPROTEIN; RATS; RATS, SPRAGUE-DAWLEY; STROKE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876458302     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12033     Document Type: Article

References (29)

1. Cordon-Cardo C, et al. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 1990; 38: 1277-1287.
2. Spudich A, et al. Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia. Nat Neurosci 2006; 9: 487-488.
3. Hermann DM, et al. Role of drug efflux carriers in the healthy and diseased brain. Ann Neurol 2006; 60: 489-498.
4. Dazert P, et al. Differential regulation of transport proteins in the periinfarct region following reversible middle cerebral artery occlusion in rats. Neuroscience 2006; 142: 1071-1079.
5. Longa EZ, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20: 84-91.
6. Lazarowski A, et al. Neuronal mdr-1 gene expression after experimental focal hypoxia: a new obstacle for neuroprotection? J Neurol Sci 2007; 258: 84-92.
7. Shimakura A, et al. Neutrophil elastase inhibition reduces cerebral ischemic damage in the middle cerebral artery occlusion. Brain Res 2000; 858: 55-60.
8. Bauer B, et al. Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Mol Pharmacol 2007; 71: 667-675.
9. Cen J, et al. HZ08, a great regulator to reverse multidrug resistance via cycle arrest and apoptosis sensitization in MCF-7/ADM. Eur J Pharmacol 2010; 647: 21-30.
10. He L, Ji BS,. In vitro and in vivo study of CJY, an isoflavone, on p-glycoprotein function in rats. J Chemother 2008; 20: 361-367.
11. Meng F, et al. Pinocembrin attenuates blood-brain barrier injury induced by global cerebral ischemia-reperfusion in rats. Brain Res 2011; 1391: 93-101.
12. Zhang L, et al. P-glycoprotein restricted transport of nimodipine across blood-brain barrier. Acta Pharmacol Sin 2003; 24: 903-906.
13. van Vliet EA, et al. COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats. Neuropharmacology 2010; 58: 404-412.
14. Zaleska MM, et al. The development of stroke therapeutics: promising mechanisms and translational challenges. Neuropharmacology 2009; 56: 329-341.
15. Loscher W, Potschka H,. Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 2005; 6: 591-602.
16. Wang Z, et al. Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J Cereb Blood Flow Metab 2011; 31: 52-57.
17. Lee G, Bendayan R,. Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders. Pharm Res 2004; 21: 1313-1330.
18. Sims NR, Muyderman H,. Mitochondria, oxidative metabolism and cell death in stroke. Biochim Biophys Acta 2010; 1802: 80-91.
19. Koto T, et al. Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am J Pathol 2007; 170: 1389-1397.
20. Shimizu F, et al. Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood-brain barrier and the blood-nerve barrier. Neurochem Res 2012; 37: 401-409.
21. Nitta T, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003; 161: 653-660.
22. Yang Y, et al. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 2007; 27: 697-709.
23. Jiao H, et al. Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult. J Mol Neurosci 2011; 44: 130-139.
24. Samoto K, et al. P-glycoprotein expression in brain capillary endothelial cells after focal ischemia in rat. Acta Neurochir Suppl (Wien) 1994; 60: 257-260.
25. Langmade SJ, et al. Pregnane X receptor (PXR) activation: a mechanism for neuroprotection in a mouse model of Niemann-Pick C disease. Proc Natl Acad Sci U S A 2006; 103: 13807-13812.
26. Linnet K, Ejsing TB,. A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs. Eur Neuropsychopharmacol 2008; 18: 157-169.
27. Miller DS, et al. Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol Rev 2008; 60: 196-209.
28. Roberts DJ, Goralski KB,. A critical overview of the influence of inflammation and infection on P-glycoprotein expression and activity in the brain. Expert Opin Drug Metab Toxicol 2008; 4: 1245-1264.
29. Clausen BH, et al. Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation 2008; 5: 46.